Pretax income is the income that a company earns before paying income taxes. AbbVie's pretax income for the
three
months ended in Dec. 2023 was $1,212 Mil.
Its pretax income for the trailing twelve months (TTM) ended in Dec. 2023 was $6,250 Mil.
AbbVie's pretax margin was 8.47%.
During the past 13 years, AbbVie's highest Pretax Margin was 30.75%. The lowest was 7.42%. And the median was 23.16%.
AbbVie Pre-Tax Income Historical Data
The historical data trend for AbbVie's Pre-Tax Income can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - General subindustry, AbbVie's Pre-Tax Income, along with its competitors' market caps and Pre-Tax Income data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
AbbVie's Pre-Tax Income Distribution in the Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, AbbVie's Pre-Tax Income distribution charts can be found below:
* The bar in red indicates where AbbVie's Pre-Tax Income falls into.
AbbVie Pre-Tax Income Calculation
This is the income that a company earns before paying income taxes.
AbbVie's Pretax Income for the fiscal year that ended in Dec. 2023 is calculated as
Pre-Tax Income for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $6,250 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
AbbVie (NYSE:ABBV) Pre-Tax Income Explanation
AbbVie's Pretax Margin for the quarter that ended in Dec. 2023 is calculated as
During the past 13 years, AbbVie's highest Pretax Margin was 30.75%. The lowest was 7.42%. And the median was 23.16%.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
AbbVie Pre-Tax Income Related Terms
Thank you for viewing the detailed overview of AbbVie's Pre-Tax Income provided by GuruFocus.com. Please click on the following links to see related term pages.
AbbVie is a pharmaceutical firm with a strong exposure to immunology and oncology. The firm's top drug, Humira, represents close to half of the company's current profits. The company was spun off from Abbott in early 2013. The recent acquisition of Allergan adds several new drugs in aesthetics and women's health.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
ABBV has been successfully added to your 